Health Catalyst HCAT Recurring technology — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Health Catalyst's recurring technology — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Health Catalyst's recurring technology — revenue?
- Health Catalyst (HCAT) reported recurring technology — revenue of $49.47M in Q1 2026.
- How has Health Catalyst's recurring technology — revenue changed year-over-year?
- Health Catalyst's recurring technology — revenue decreased by 3.9% year-over-year, from $51.48M to $49.47M.
- What is the long-term trend for Health Catalyst's recurring technology — revenue?
- Over 4 years (2021 to 2025), Health Catalyst's recurring technology — revenue has grown at a 9.0% compound annual growth rate (CAGR), from $147.45M to $208.28M.
- What does recurring technology — revenue mean?
- This metric represents the total revenue generated from cloud-based subscription arrangements, software licenses, and associated maintenance and support services within the technology segment. It serves as a primary indicator of the company's ability to scale its core data platform and analytics software offerings. Growth in this segment reflects the successful adoption and retention of the company's technology solutions by healthcare organizations.